Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
koronarintervention
coronary intervention
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
perkutan koronarintervention (pci)
percutaneous coronary intervention (pci)
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
för koronarintervention, se avsnitt 4.4.
for coronary intervention see section 4.4.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
som antikoagulantia till patienter som genomgår perkutan koronarintervention (pci).
an anticoagulant in patients undergoing percutaneous coronary intervention (pci).
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 2
Kalite:
tabell 4 visar effektresultaten hos patienter som genomgått perkutan koronarintervention (pci).
in table 4 the efficacy results of patients undergoing percutaneous coronary intervention (pci) are presented.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
prasugrels farmakokinetik är likartad hos friska försökspersoner, patienter med stabil ateroskleros och patienter som genomgår perkutan koronarintervention.
prasugrel’s pharmacokinetics are similar in healthy subjects, patients with stable atherosclerosis, and patients undergoing percutaneous coronary intervention.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
stemi patienter som planerades genomgå primär koronarintervention kunde randomiseras inom 12 timmar efter symtomens uppträdande utan kännedom om koronaranatomin.
patients with stemi within 12 hours of symptoms and planned for primary pci could be randomised without knowledge of coronary anatomy.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
c: observerad som mindre vanlig vid förebyggande av aterotrombotiska händelser efter akut koronarsyndrom (efter perkutan koronarintervention)
c: observed as uncommon in prevention of atherothrombotic events in patients after an acs (following percutaneous coronary intervention)
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
bivalirudins farmakokinetiska egenskaper har utvärderats och funnits vara linjära hos patienter som genomgår perkutan koronarintervention (pci) och patienter med aks.
the pharmacokinetic properties of bivalirudin have been evaluated and found to be linear in patients undergoing percutaneous coronary intervention and in patients with acs.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
om perkutan koronarintervention (pci) utförs under behandling med eptifibatid ska infusionen fortgå i 20-24 timmar efter pci i sammanlagt högst 96 timmar.
if percutaneous coronary intervention (pci) is performed during eptifibatide therapy, continue the infusion for 20-24 hours post-pci for an overall maximum duration of therapy of 96 hours.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 4
Kalite:
den farmakoinvasiva strategin bestod i tidig fibrinolytisk behandling med en bolusdos tenecteplas samt ytterligare trombocythämmande och antikoagulationsbehandling följt av angiografi inom 6-24 timmar eller s.k. rescue koronarintervention.
the pharmaco-invasive strategy consisted of early fibrinolytic treatment with bolus tenecteplase and additional antiplatelet and anticoagulant therapy followed by angiography within 6-24 hours or rescue coronary intervention.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
om en patient ska genomgå perkutan koronarintervention (pci) ska ofraktionerat heparin (ufh) ges under pci enligt lokal praxis med hänsyn tagen till patientens potentiella blödningsrisk inklusive tidpunkten för senast intagna fondaparinuxdos (se avsnitt 4.4.).
if a patient is to undergo percutaneous coronary intervention (pci), unfractionated heparin (ufh) as per local practice should be administered during pci, taking into account the patient’s potential risk of bleeding, including the time since the last dose of fondaparinux (see section 4.4).
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite: